About: Labion
Recent Posts by Labion
LABION obtained funding from Italian Ministry of Health to acquire new equipments that will be used for the development of innovative biomarkers and to validate them in clinical trials in the field of rehabilitation medicine.
The new equipments will allow to carry on a project research aimed at predicting the outcome of post-stroke...
Read more
Meeting report on Regenerative Rehabilitation is online and available!
The Meeting report about the last Symposium on Regenerative Rehabilitation in Virginia is now available online! Dr. Bedoni and Dr.Picciolini collaborated with Dr. Cheuy in writing a post-symposium summary to share the great and interesting experience in Cherlotteville last October.
We suggest to have a look at this report that explains the updated advances of...
Read more
LABION @Nanoinnovation2020
Tomorrow, 16th September 2020 LABION - Fondazione Don Gnocchi has the pleasure to chair two tematic sessions together with University of Modena e Reggio Emilia
Register and follow remotely our thematic session and all the interesting talk of the national meeting place for the wide and multidisciplinary...
Read more
We are hiring!
Temporary position for a JUNIOR SCIENTIST
JOB DESCRIPTION:
we are looking for a junior scientist interested in the application of advanced optical techniques (Raman spectroscopy and Surface Plasmon Resonance Imaging) and nanomaterials in medicine. The research activity of the candidate will be aimed to perform the quality control of drug-loaded nanovectors, evaluating both process reproducibility and...New frontiers in ALS diagnosis
Labion is proud to communicate the open access publication of recent results on the diagnosis of Amiotrophic Lateral Sclerosis (ALS) by Raman analysis of SALIVA!
Labion in collaboration with the Respiratory Rehabilitation Unit of IRCCS S. Maria Nascente (Head: Dr. Paolo Banfi) and Istituto Auxologico Italiano (Prof. Vincenzo...
Read more
Labion updates
The last months have been hard for all of us, all over the world.
Labion activity never stopped: we have met through all kind of digital platforms to keep updated with our collaborators and colleagues, we have written projects for grant request and articles with recent findings.
Now that our beloved laboratory activity is allowed under strict...
Read more
KICK OFF MEETING OF NEVERMIND PROJECT!
Today, the Kick off meeting of NEVERMIND project took place at IRCCS Fondazione Don Gnocchi of Milan. During this event, the coordinator and the partners had the opportunity to present how they will contribute to the project thanks to their specific expertise and skills.
The Consortium has shown to be very motivated, proactive and...
Labion SERS analysis published on Journal of Biophotonics
Labion is working on a project regarding the development of a diagnostic and monitoring tool based on Raman spectroscopy combined with silver nanoparticles. This biophotonic-based platform is able to provide information regarding the onset of Alzheimer's disease and about the neurological tissue degeneration caused by the pathological progression. Labion has now published these findings that are opening the...
Read more
Benvenuta Arianna!
Il LABION è lieto di accogliere Arianna Iannone, studentessa di biotecnologie che ha scelto di svolgere il suo tirocinio per la laurea magistrale presso il nostro laboratorio. Il progetto su cui lavorerà Arianna è finalizzato all’utilizzo di una piattaforma di biofotonica per l’identificazione e la caratterizzazione di vescicole extracellulari in pazienti affetti da malattia di...
Read more
JOB ADVERTISEMENT!
Temporary position for a chemist/biotechnologist/biologist/biomedical engineer
Fondazione Don Carlo Gnocchi (FDG) is a 60 years old, not-for-profit leading institution in healthcare and rehabilitation, holding a chain of 29 healthcare centres and research hospitals in Italy and employing more than 6.000 people.
Since 30 years, a biomedical technology department is present in FDG, named Polo Tecnologico, based in...
Read more
Recent Comments by Labion
No comments by Labion yet.